Australia, July 24 -- Glaxo Group Ltd., owns the trademark (2622613) for 'BAVRIZTO' till Dec. 19, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines.]
Type of Mark: Word
Date of Acceptance: Feb. 24
Registration Advertised: July 23
For further details contact GSK Legal Brand Protection.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2622613.
Disclaimer: Curated by HT Syndication....